Unusually, it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors, which are also involved in managing insulin release, fat storage, metabolism, and appetite
The standard recommendation of 0.8 g per pound of body weight applies here, but some evidence suggests 1.01.2 g per pound is more protective during aggressive weight loss with appetite suppressants
But chronic high-dose use may: Overstimulate metabolic pathways Alter methylation balance (since NNMT is tied to methyl donor cycling) Lead to unintended side effects like fatigue, irritability, or hormonal imbalance Stick to researched dosing windows (typically 1020 mg/day for short cycles in animal models) 2
It is one of the most studied GHRP (Growth Hormone Releasing Peptide) compounds in published research literature, frequently investigated alongside CJC-1295 due to their complementary mechanisms in GH-pathway research
Compare independent results to supplier COA
Global epidemiology of nonalcoholic fatty liver diseaseMetaanalytic assessment of prevalence, incidence, and outcomes
/assets/images/provider/photos/2813769.png)
